Workshop report: The 2012 antimicrobial agents in veterinary medicine: Exploring the consequences of antimicrobial drug use: A 3-D approach

Journal of Veterinary Pharmacology and Therapeutics

Volumn 37, Issue 1, 2014, Pages e1-e16

  Martinez, M ^a   Blondeau, J ^b   Cerniglia, C E ^c   Fink Gremmels, J ^d   Guenther, S ^e   Hunter, R P ^f   Li, X Z ^g   Papich, M ^h   Silley, P ⁱ   Soback, S ^j   Toutain, P L ^k   Zhang, Q ^l  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^d UTRECHT UNIVERSITY   (Netherlands)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

^f ELANCO ANIMAL HEALTH   (United States)

^g HEALTH CANADA   (Canada)

^h NORTH CAROLINA STATE UNIVERSITY   (United States)

ⁱ UNIVERSITY OF BRADFORD   (United Kingdom)

^j KIMRON VETERINARY INSTITUTE   (Israel)

^k TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

^l IOWA STATE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACID; AMDINOPENICILLIN DERIVATIVE; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CEPHAMYCIN DERIVATIVE; CHLORAMPHENICOL; DIHYDROFOLATE REDUCTASE INHIBITOR; ESTER DERIVATIVE; GLYCOPEPTIDE; KETOLIDE; LINCOSAMIDE; LIPOPEPTIDE; MACROLIDE; MONOBACTAM DERIVATIVE; NITROIMIDAZOLE DERIVATIVE; OXAZOLIDINONE DERIVATIVE; PENICILLIN DERIVATIVE; PLEUROMUTILIN; PSEUDOMONIC ACID; QUINOLONE DERIVATIVE; STEROID; STEROID ANTIBACTERIAL; STREPTOGRAMIN DERIVATIVE; SULFONAMIDE; SULFONE; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VETERINARY DRUG;

ACCEPTABLE DAILY INTAKE; ANIMAL DISEASE; ANIMAL HEALTH; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL TRANSMISSION; CAMPYLOBACTER JEJUNI; CAMPYLOBACTERIOSIS; DIET; DOMESTIC ANIMAL; DRUG CLASSIFICATION; DRUG DOSE; DRUG EFFICACY; DRUG SAFETY; DRUG USE; ENVIRONMENT; ESCHERICHIA COLI; FOOD AND DRUG ADMINISTRATION; FOOD CHAIN; HUMAN; INTESTINE FLORA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUTRITIONAL PARAMETERS; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; SALMONELLA; VETERINARY MEDICINE; WORKSHOP;

ANIMALIA;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HUMANS; VETERINARY MEDICINE;

EID: 84891642084     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/jvp.12104     Document Type: Article

References (76)

1. Ahn, Y., Linder, S.W., Veach, B.T., Yan, S., Fernández, H.A., Pineiro, S.A. & Cerniglia, C.E. (2010) In vitro enrofloxacin binding in human fecal slurries. Regulatory Pharmacology and Toxicology, 62, 74-84.
2. Ambrose, P.G., Bhavnani, S.M., Rubino, C.M., Louie, A., Gumbo, T., Forrest, A. & Drusano, G.L. (2007) Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore. Clinical Infectious Diseases, 44, 79-86.
3. Anon 1. EFSA (2012) European Food Safety Authority; Technical specifications on the harmonised monitoring and reporting of antimicrobial resistance in Salmonella, Campylobacter and indicator Escherichia coli and Enterococcus spp. bacteria transmitted through food. EFSA Journal, 10, 2742.
4. Anon 2. OIE Terrestrial Animal Health Code (2012). http://www.oie.int/international-standard-setting/terrestrial-code/access-online/.
5. Anon 3. US FDA CVM Guidance for Industry #120. Veterinary Feed Directive Regulation Questions and Answers. http://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/UCM052660.pdf.
6. Anon 4. US FDA CVM Guidance for Industry #209. The Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals. http://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/UCM216936.pdf.
7. Anon 5. US FDA CVM Guidance for Industry #213. New Animal Drugs and New Animal Drug Combination Products Administered in or on Medicated Feed or Drinking Water of Food-Producing Animals: Recommendations for Drug Sponsors for Voluntarily Aligning Product Use Conditions with GFI #209. http://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/UCM299624.pdf.
8. Anon 6. VICH Guidelines, Guideline #36. http://www.vichsec.org/en/guidelines5.htm.
9. Anon 7. World Health Organization, Critically Important Antimicrobials for Human Medicine, 3rd Revision (2011). http://apps.who.int/iris/bitstream/10665/77376/1/9789241504485_eng.pdf.
10. Anon 8. World Health Organization, Foodborne Disease Surveillance, Antimicrobial Resistance. http://www.who.int/foodborne_disease/resistance/en/.
11. Anon 9. European Centre for Disease Prevention and Control, EARS-Net Database. http://ecdc.europa.eu/en/activities/surveillance/EARS-net/database/Pages/database.aspx.
12. Bemis, D.A., Jones, R.D., Frank, L.A. & Kania, S.A. (2009) Evaluation of susceptibility test breakpoints used to predict mecA-mediated resistance in Staphylococcus pseudintermedius isolated from dogs. Journal of Veterinary Diagnostic Investigation, 21, 53-58.
13. Bhullar, K., Waglechner, N., Pawlowski, A., Koteva, K., Banks, E.D., Johnston, M.D., Barton, H.A. & Wright, G.D. (2012) Antibiotic resistance is prevalent in an isolated cave microbiome. PLoS One, 7, e34953.
14. Blaser, M.J. & Engberg, J. (2008). Clinical aspects of Campylobacter jejuni and Campylobacter coli infections. In Campylobacter. Eds Nachamkin, I., Szymanski, C.M. & Blaser, M.J., pp. 99-121. American Society for Microbiology, Washington, DC.
15. Blickwede, M., Valentin-Weigand, P. & Schwarz, S. (2004) Sub-inhibitory concentrations of florfenicol enhance the adherence of florfenicol-susceptible and florfenicol-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy, 54, 286-288.
16. Blondeau, J.M. (2009) New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach. Veterinary Dermatology, 20, 383-396.
17. Blondeau, J.M., Zhao, X., Hansen, G. & Drlica, K. (2001) Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy, 45, 433-438.
18. Blondeau, J.M., Hansen, G., Metzler, K. & Hedlin, P. (2004) The role of PK/PD parameters to avoid selection and increase of resistance: mutant prevention concentration. Journal of Chemotherapy, 16(Suppl. 3), 1-19.
19. Cegelski, L., Marshall, G.R., Eldridge, G.R. & Hultgren, S.J. (2008) The biology and future prospects of antivirulence therapies. Nature Review Microbiology, 6, 17-27.
20. Centers for Disease Control and Prevention (CDC) (2013) Incidence and trends of infection with pathogens transmitted commonly through food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 1996-2012. Morbidity & Mortality Weekly Report, 62, 283-287.
21. Cerniglia, C.E. & Kotarski, S. (1999) Evaluation of veterinary drug residues in food for their potential to affect human intestinal microflora. Regulatory Pharmacology and Toxicology, 29, 238-261.
22. Cerniglia, C.E. & Kotarski, S. (2005) Approaches in the safety evaluations of veterinary antimicrobial agents in food to determine the effects on the human intestinal microflora. Journal of Veterinary Pharmacology & Therapeutics, 28, 3-20.
23. Christensen, E.G., Gram, L. & Kastbjerg, V.G. (2011) Sublethal triclosan exposure decreases susceptibility to gentamicin and other aminoglycosides in Listeria monocytogenes. Antimicrobial Agents and Chemotherapy, 55, 4064-4071.
24. Cogliani, C., Goossens, H. & Greko, C. (2011) Restricting antimicrobial use in food animals: lessons from Europe. Microbe, 6, 274-279.
25. Craig, W.A. (2007). Pharmacodynamics of antimicrobials: general concepts and applications. In Antimicrobial Pharmacodynamics in Theory and Practice, 2nd edn. Eds Nightingale, C.H., Ambrose, P.G., Drusano, G.L. & Murakawa, T., pp. 1-22. Marcel Dekker Publishers, New York.
26. Davies, J., Spiegelman, G.B. & Yim, G. (2006) The world of sub-inhibitory antibiotic concentrations. Current Opinion in Microbiology, 9, 445-453.
27. D'Costa, V.M., King, C.E., Kalan, L., Morar, M., Sung, W.W., Schwarz, C., Froese, D., Zazula, G., Calmels, F., Debruyne, R., Golding, G.B., Poinar, H.N. & Wright, G.D. (2011) Antibiotic resistance is ancient. Nature, 477, 457-461.
28. Denève, C., Deloménie, C., Barc, M.C., Collignon, A. & Janoir, C. (2008) Antibiotics involved in Clostridium difficile-associated disease increase colonization factor gene expression. Journal of Medical Microbiology, 57, 732-738.
29. Drlica, K. (2003) The mutant selection window and antimicrobial resistance. Journal of Antimicrobial Chemotherapy, 52, 11-17.
30. van Duijkeren, E., Box, A.T., Heck, M.E., Wannet, W.J. & Fluit, A.C. (2004a) Methicillin-resistant staphylococci isolated from animals. Veterinary Microbiology, 103, 91-97.
31. van Duijkeren, E., Wolfhagen, M.J., Box, A.T., Heck, M.E., Wannet, W.J. & Fluit, A.C. (2004b) Human-to-dog transmission of methicillin-resistant Staphylococcus aureus. Emerging Infectious Diseases, 10, 2235-2237.
32. Escaich, S. (2010) Novel agents to inhibit microbial virulence and pathogenicity. Expert Opinion on Therapeutic Patents, 20, 1401-1418.
33. Ewers, C., Grobbel, M., Stamm, I., Kopp, P., Fruth, A., Diehl, I., Semmler, T., Bethe, A., Wieler, L.H. & Guenther, S. (2010) First Insight into the Population Structure, Resistance Features and Virulence Genotype of Extended Spectrum B-Lactamase Producing Escherichia coli from Companion Animals. 2nd ASM Conference on Antimicrobial Resistance in Zoonotic Bacteria and Foodborne Pathogens in Animals, Humans and the Environment, Toronto, Canada ISBN 987-1-55581-629-2.
34. Ewers, C., Bethe, A., Semmler, T., Guenther, S. & Wieler, L.H. (2012) Extended-spectrum β-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective. Clinical Microbiology and Infection, 18, 646-655.
35. Ferran, A., Dupouy, V., Toutain, P.L. & Bousquet-Mélou, A. (2007) Influence of inoculum size on the selection of resistant mutants of Escherichia coli in relation to mutant prevention concentrations of marbofloxacin. Antimicrobial Agents and Chemotherapy, 51, 4163-4166.
36. Ferran, A.A., Toutain, P.L. & Bousquet-Mélou, A. (2011) Impact of early versus later fluoroquinolone treatment on the clinical; microbiological and resistance outcomes in a mouse-lung model of Pasteurella multocida infection. Veterinary Microbiology, 24, 292-297.
37. Frisch, A.W., Tripp, J.T., Barrett, C.D. & Pidgeon, B.E. (1942) The specific polysaccharide content of pneumonic lungs. Journal of Experimental Medicine, 76, 505-510.
38. Garch, F., Lismond, A., Piddock, L.J., Courvalin, P., Tulkens, P.M. & Van Bambeke, F. (2010) Fluoroquinolones induce the expression of patA and patB, which encode ABC efflux pumps in Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy, 65, 2076-2082.
39. Guenther, S., Grobbel, M., Beutlich, J., Guerra, B., Ulrich, R.G., Wieler, L.H. & Ewers, C. (2010a) Detection of pandemic B2-O25-ST131 Escherichia coli harbouring the CTX-M-9 extended-spectrum beta-lactamase type in a feral urban brown rat (Rattus norvegicus). Journal of Antimicrobial Chemotherapy, 65, 582-584.
40. Guenther, S., Grobbel, M., Lübke-Becker, A., Goedecke, A., Friedrich, N.D., Wieler, L.H. & Ewers, C. (2010b) Antimicrobial resistance profiles of Escherichia coli from common European wild bird species. Veterinary Microbiology, 1441, 219-225.
41. Guenther, S., Bethe, A., Fruth, A., Semmler, T., Ulrich, R.G., Wieler, L.H. & Ewers, C. (2012) Frequent combination of antimicrobial multiresistance and extraintestinal pathogenicity in Escherichia coli isolates from urban rats (Rattus norvegicus) in Berlin, Germany. PLoS One, 7, e50331.
42. Hansen, G.T., Metzler, K., Drlica, K. & Blondeau, J.M. (2003) Mutant concentration of gemifloxacin for clinical isolates of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy, 47, 440-441.
43. Hesje, C.K., Tillotson, G.S. & Blondeau, J.M. (2007) MICs, MPCs, PK/PDs: a match (sometimes) made in hosts. Expert Review of Respiratory Medicine, 1, 7-16.
44. Hoffman, L.R., D'Argenio, D.A., MacCoss, M.J., Zhang, Z., Jones, R.A. & Miller, S.I. (2005) Aminoglycoside antibiotics induce bacterial biofilm formation. Nature, 436, 1171-1175.
45. Human Microbiome Project Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature, 486, 207-214.
46. Jeffery, I.B., Claesson, M.J., O'Toole, P.W. & Shanahan, F. (2012) Categorization of the gut microbiota: enterotypes or gradients? Nature Review Microbiology, 10, 591-592.
47. Jernberg, C., Löfmark, S., Edlund, C. & Jansson, J.K. (2010) Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology, 56, 3216-3223.
48. Jones, R.D., Kania, S.A., Rohrbach, B.W., Frank, L.A. & Bemis, D.A. (2007) Prevalence of oxacillin- and multidrug-resistant staphylococci in clinical samples from dogs: 1, 772 samples (2001-2005). Journal of the American Veterinary Medical Association, 230, 221-227.
49. de Jong, A., Stephan, B. & Silley, P. (2012) Fluoroquinolone resistance of Escherichia coli and Salmonella from healthy livestock and poultry in the EU. Journal of Applied Microbiology, 112, 239-245.
50. Kahlmeter, G., Brown, D.F.J., Goldstein, F.W., MacGowan, A.P., Mouton, J., Österlund, A., Rodloff, A., Steinbakk, M., Urbaskova, P. & Vatopoulos, A. (2003) European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. Journal of Antimicrobial Chemotherapy, 52, 145-148.
51. Kaldhone, P., Nayak, R., Lynne, A.M., David, D.E., McDermott, P.F., Logue, C.M. & Foley, S.L. (2008) Characterization of Salmonella enterica serovar Heidelberg from turkey-associated sources. Applied Environmental Microbiology, 74, 5038-5046.
52. Kesteman, A.S., Perrin-Guyomard, A., Laurentie, M., Sanders, P., Toutain, P.L. & Bousquet-Mélou, A. (2010) Emergence of resistant Klebsiella pneumoniae in the intestinal tract during successful treatment of Klebsiella pneumoniae lung infection in rats. Antimicrobial Agents and Chemotherapy, 54, 2960-2964.
53. Kim, B.S., Kim, J.N. & Cerniglia, C.E. (2011) In vitro culture conditions for maintaining a complex population of human gastrointestinal tract microbiota. Journal of Biomedicine & Biotechnology, Article ID 838040, 1-10.
54. Kim, B.S., Kim, J.N., Yoon, S.H., Chun, J. & Cerniglia, C.E. (2012) Impact of enrofloxacin on the human intestinal microbiota revealed by comparative molecular analysis. Anaerobe, 18, 310-320.
55. Lin, J., Yan, M., Sahin, O., Pereira, S., Chang, Y.J. & Zhang, Q. (2007) Effect of macrolide usage on emergence of erythromycin-resistant Campylobacter isolates in chickens. Antimicrobial Agents and Chemotherapy, 51, 1678-1686.
56. Looft, T., Johnson, T.A., Allen, H.K., Bayles, D.O., Alt, D.P., Stedtfeld, R.D., Sul, W.J., Stedtfeld, T.M., Chai, B., Cole, J.R., Hashsham, S.A., Tiedje, J.M. & Stanton, T.B. (2012) In-feed antibiotic effects on the swine intestinal microbiome. Proceedings of the National Academy of Sciences, USA, 109, 1691-1696.
57. Luangtongkum, T., Morishita, T.Y., Ison, A.J., Huang, S., McDermott, P.F. & Zhang, Q. (2006) Effect of conventional and organic production practices on the prevalence and antimicrobial resistance of Campylobacter spp. in poultry. Applied Environmental Microbiology, 72, 3600-3607.
58. Luo, N., Pereira, S., Sahin, O., Lin, J., Huang, S., Michel, L. & Zhang, Q. (2005) Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure. Proceedings National Academy of Science, USA, 102, 541-546.
59. Majtán, J., Majtánová, L., Xu, M. & Majtán, V. (2008) In vitro effect of sub-inhibitory concentrations of antibiotics on biofilm formation by clinical strains of Salmonella enterica serovar Typhimurium isolated in Slovakia. Journal of Applied Microbiology, 104, 1294-1301.
60. Marsik, F.J. & Parisi, J.T. (1973) Significance of Staphylococcus epidermidis in the clinical laboratory. Applied Microbiology, 25, 11-14.
61. Martinez, M.N., Papich, M.G. & Drusano, G.L. (2012) Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target. Antimicrobial Agents and Chemotherapy, 56, 2795-2805.
62. Martinez, M.N., Toutain, P.-L. & Turnnidge, J. (2013). The pharmacodynamics of antimicrobial agents. In Antimicrobial Therapy in Veterinary Medicine, 5th edn. Eds Giguère, S., Prescott, J.F. & Dowling, P.M., pp. 79-103. Wiley Blackwell, Ames, Iowa.
63. Matlow, A.G. & Morris, S.K. (2009) Control of antibiotic-resistant bacteria in the office and clinic. Canadian Medical Association Journal, 180, 1021-1024.
64. Papich, M.G. (2012) Selection of antibiotics for meticillin-resistant Staphylococcus pseudintermedius: time to revisit some old drugs? Veterinary Dermatology, 23, 352-360.
65. Petrof, E.O., Claud, E.C., Gloor, G.B. & Allen-Vercoe, E. (2012) Microbial ecosystems therapeutics: a new paradigm in medicine? Beneficial Microbes, 20, 1-13.
66. Possemiers, S., Grootaert, C., Vermeiren, J., Gross, G., Marzorati, M., Verstraete, W. & Van de Wiele, T. (2009) The intestinal environment in health and disease - recent insights on the potential of intestinal bacteria to influence human health. Current Pharmaceutical Design, 15, 2051-2065.
67. Rasigade, J.P., Moulay, A., Lhoste, Y., Tristan, A., Bes, M., Vandenesch, F., Etienne, J., Lina, G., Laurent, F. & Dumitrescu, O. (2011) Impact of sub-inhibitory antibiotics on fibronectin-mediated host cell adhesion and invasion by Staphylococcus aureus. BMC Microbiology, 11, 263-272.
68. Reeks, B.Y., Champlin, F.R., Paulsen, D.B., Scruggs, D.W. & Lawrence, M.L. (2005) Effects of sub-inhibitory concentration antibiotic levels and temperature on growth kinetics and outer membrane protein expression in Mannheima haemolytica and Haemophilus somnus. Canadian Journal of Veterinary Research, 69, 1-10.
69. Ruiz-Palacios, G.M. (2007) The health burden of Campylobacter infection and the impact of antimicrobial resistance: playing chicken. Clinical Infectious Diseases, 44, 701-703.
70. Silley, P., de Jong, A., Simjee, S. & Thomas, V. (2011) Harmonisation of resistance monitoring programmes in veterinary medicine: an urgent need in the EU? International Journal of Antimicrobial Agents, 37, 504-512.
71. Simmons, J. (2011). Technology's Role in the 21st Century: Making Safe, Affordable and Abundant Food a Global Reality. https://www.ncbiotech.org/sites/default/files/pages/Three-Rights-White-Paper-Revised.pdf
72. Song, B., Wang, G.R., Shoemaker, N.B. & Salyers, A.A. (2009) An unexpected effect of tetracycline concentration: growth phase-associated excision of the Bacteroides mobilizable transposon NBU1. Journal of Bacteriology, 191, 1078-1082.
73. Tan, C., Smith, R.P., Srimani, J.K., Riccione, K.A., Prasada, S., Kuehn, M. & You, L. (2012) The inoculum effect and band-pass bacterial response to periodic antibiotic treatment. Molecular Systems Biology, 8, 617-627.
74. Udekwu, K.I., Parrish, N., Ankomah, P., Baquero, F. & Levin, B.R. (2009) Functional relationship between bacterial cell density and the efficacy of antibiotics. Journal of Antimicrobial Chemotherapy, 63, 745-757.
75. Vaarten, J. (2012) Clinical impact of antimicrobial resistance in animals. Revue scientifique et technique (International Office of Epizootics), 31, 221-229.
76. Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.Y., Keilbaugh, S.A., Bewtra, M., Knights, D., Walters, W.A., Knight, R., Sinha, R., Gilroy, E., Gupta, K., Baldassano, R., Nessel, L., Li, H., Bushman, F.D. & Lewis, J.D. (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science, 334, 105-108.